Magistrate Judge Issues Report and Recommendation to Award KORU Medical Systems $1.0 Million in Attorneys’ Fees and Costs
November 14 2019 - 4:10PM
Business Wire
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:
KRMD) (“KORU Medical” or the “Company”) today announced that on
November 12, 2019 a United States District Court Magistrate Judge
for the Southern District of New York issued a Report and
Recommendation that KORU Medical’s motion to declare the patent
infringement case exceptional and recoup attorneys’ fees and
expenses from EMED Technologies (“EMED”) should be granted in the
amount of $1,012,527.67. As previously announced, on August 30,
2019 the United States District Court for the Southern District of
New York granted KORU Medical’s motion for summary judgement of
non-infringement against EMED U.S. Patent 9,808,576 and dismissed
the case (1:18-cv-05880-LGS) with prejudice.
The Report and Recommendation of the Magistrate Judge serving in
the United States District Court for the Southern District of New
York is not a final decision and will be reviewed, along with any
potential objections raised by EMED, by the District Judge for the
United States District Court for the Southern District of New York.
KORU Medical believes that the District Judge will confirm the
Report and Recommendation of the Magistrate Judge, although there
can be no assurances as to the outcome or timing.
KORU Medical is also pursuing the recovery of attorneys’ fees
and expenses from EMED in a separate case that was, as previously
announced, dismissed by the United States District Judge for the
Eastern District of Texas on June 28, 2019. There can be no
assurances that KORU Medical will be successful in this
pursuit.
About KORU Medical Systems
KORU Medical Systems develops, manufactures and commercializes
innovative and easy-to-use specialty infusion solutions that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and
FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™
and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
Forward-Looking
Statements
The statements contained herein include prospects, statements of
future expectations and other forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that are based on management's current views and assumptions and
involve known and unknown risks and uncertainties, identified by
words such as “believes”. Actual results, performance or events may
differ materially from those expressed or implied in such
forward-looking statements. Factors that may cause actual results
to differ materially from current expectations include actual
outcome of judicial review and other risks discussed in the
Company’s filings with the U.S. Securities and Exchange Commission,
including its Annual Report on Form 10-K, which filings are
available from the SEC and the Company’s website. The Company
undertakes no obligation to update any forward-looking
statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191114005789/en/
The Equity Group Inc. Devin Sullivan Senior Vice
President 212-836-9608 dsullivan@equityny.com
Kalle Ahl, CFA Vice President 212-836-9614 kahl@equityny.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024